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for supramolecular host–guest complexes†
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Christian Spies,d Eduard Spuling, b Liu-Pan Yang,e Wei Jiang,e Stefan Bräse *bf
and Frank Biedermann *a
Fluorescence-detected circular dichroism (FDCD) spectroscopy is applied for the first time to
supramolecular host–guest and host–protein systems and compared to the more known electronic
circular dichroism (ECD). We find that FDCD can be an excellent choice for common supramolecular
applications, e.g. for the detection and chirality sensing of chiral organic analytes, as well as for reaction
monitoring. Our comprehensive investigations demonstrate that FDCD can be conducted in favorable
circumstances at much lower concentrations than ECD measurements, even in chromophoric and auto-
emissive biofluids such as blood serum, overcoming the sensitivity limitation of absorbance-based
chiroptical spectroscopy. Besides, the combined use of FDCD and ECD can provide additional valuable
information about the system, e.g. the chemical identity of an analyte or hidden aggregation
phenomena. We believe that simultaneous FDCD- and ECD-based chiroptical characterization of
emissive supramolecular systems will be of general benefit for characterizing fluorescent, chiral
supramolecular systems due to the higher information content obtained by their combined use.Introduction
Investigations into the chirality of (bio)chemical systems and
monitoring of chiral transformations have provided useful
lessons for the design of drugs and functional materials and
enriched the general understanding of molecular recognition
principles.1–3 Electronic circular dichroism (ECD) spectroscopy,
which measures the difference in the absorption of le and
right circularly polarized light (Fig. 1), has been extensively used
for the characterization of chiral, light-absorbing molecules.4–7
Most of the (bio)chemical compounds of interest lack a strong
chromophoric group and hence, do not produce ECD signals in
the practically preferable near UV or visible wavelength region, or
are even completely ECD silent. This has prompted the develop-
ment of chromophoric probes and chemosensors which engage), Institute of Nanotechnology (INT),
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31in covalent or non-covalent interactions with the chiral ana-
lyte.8–11 The complexation of a chiral analyte by an achiral chro-
mophoric “binder” can generally be expected to give rise to
chiroptical signals because the chromophore is then situated in
a chiral environment.12–14 Practically, suitably strong emergingFig. 1 Complexation of a chiral guest by an achiral chromophoric and
emissive host can induce ECD and FDCD signal generation. The ECD
signal measures the difference in absorption of left-handed and right-
handed circularly polarized light by the chiral species whereas FDCD
reports on the differential fluorescence intensity that results from
excitation with left-handed and right-handed circularly polarized light.
© 2021 The Author(s). Published by the Royal Society of Chemistry
Fig. 2 Chemical structure of (a) host, (b) dye molecules and (c) investigated chiral analytes and the achiral drug memantine utilized in this study.
Their protonation state represents their occurrence under the measurement conditions. The hosts and the self-assembled CB8$MDPP receptor
complex are depicted in bold in the manuscript whereas for the guests the normal font is used.























































































View Article OnlineECD signals are usually obtained if an electronic-coupling
between the chromophoric host and the chiral guest occurs, or
if the host deforms into a chiral conformation upon analyte
binding.15 In favourable cases, ECD spectra can contain analyte-
specic “induced ECD ngerprints”, which can be utilized for
analyte identication and differentiation.14–16 Representative
supramolecular ECD-based probes and chemosensors were
described by Berova,12,17 Borhan,18–20 Wolf,16,21–23 Anslyn,13,24–26
Canary,26–28 Nau,14,29,30 Jiang,11 our group14,15 and others.31–33
Chirality-sensors that operate in aqueous media are particularly
attractive because of their application potential in the Life
Sciences and for diagnostics.11,14,34 For instance, chemosensors
that were modularly assembled from the large macrocycle
cucurbit[8]uril (CB8, see Fig. 2a) and dicationic reporter dyes in
water, respond with induced, analyte-indicative ECD signals to
the presence of biorelevant chiral aromatic metabolites such as
Trp-containing peptides.14
The concentration range where ECD measurements can be
applied depends on the intensity of dichroic absorption, and is
thus rather narrow.35,36 Specically, the ECD detection limit is
set by the molar extinction coefficient of the chromophoric host
(or guest), which rarely reaches 105 M1 cm1. Consequently,
receptor and analyte concentrations $10 mM, oentimes even
>100 mM, have to be used for generating meaningful ECD
signals.11,14,37 However, many diagnostically relevant analytes
only occur in the low micromolar to nanomolar regime in bio-
uids, and thus escape ECD-based detection protocols. More-
over, most biomolecules and articial supramolecular systems
are prone to aggregate in aqueous environments, which
prohibits the use of high concentrations.
The use of uorescence-based chiroptical methods comes to
mind in an effort to improve the sensitivity of chiroptical
supramolecular assays. Both uorescence-detected circular© 2021 The Author(s). Published by the Royal Society of Chemistrydichroism (FDCD) spectroscopy38–40 as well as circularly polar-
ized luminescence (CPL) spectroscopy41–46 are worth consid-
ering, with the latter receiving a revival in recent years. In
essence, CPL measures the circularly polarized emission from
a chiral emitter,47 while FDCD is probing differences in the
excitation spectrum when the sample is irradiated with circu-
larly polarized light, see Fig. 1.48,49 However, a bibliometric
analysis of the available literature revealed that less than 70
studies have mentioned the term ‘uorescence-detected
circular dichroism’ in the abstract while over 1500 studies
have mentioned ‘circularly polarized luminescence’ and more
than 2600 studies have referred to the term ‘electronic circular
dichroism’ (with over 60 000 mentioning ‘circular dichroism’,
which is oen used as a synonym for ECD).50 One of the rst
reports on FDCD dates back to 1974, where the chiral uo-
rophore tryptophan was selectively detected in a mixture con-
taining the non-emissive chromophore cysteine.38,48 Later on,
exciton coupled FDCD measurements were, for instance
directed towards tertiary structure analysis of proteins,51 the
stereochemical analysis of steroids covalently tethered to
a porphyrin centre38 and for investigating the formation of DNA
bichromophore assemblies.52
In this study, we investigated into uorescence-detected
circular dichroism (FDCD) spectroscopy for representative
supramolecular host–guest systems and present a case study for
the combined use of FDCD and ECD spectroscopy for charac-
terising uorescent supramolecular chiral systems.Results
Compound selection
Self-assembled CB8$MDPP chemosensor and endo-
functionalized molecular tube (MT) were chosen as achiralChem. Sci., 2021, 12, 9420–9431 | 9421























































































View Article Onlinechromophoric and emissive hosts, and CB8 was used as a non-
chromophoric achiral host for comparison. New planar-chiral
paracyclophane dyes are introduced as chiral indicators. As
guests, a wide range of biorelevant chiral compounds was used,
including amino acids (e.g. Phe, Trp), amino acid derivatives,
peptides and synthetic intermediates (chiral epoxides). The
protein insulin, that bind to the host CB8$MDPP was also
investigated. The chemical structures of the hosts, guests and
dyes are depicted in Fig. 2.
Synthesis of new chiral paracyclophane dyes
The enantiomers of the paracyclophane-derived dye MPCP, (SP)-
MPCP ((Sp)-3a) and (RP)-MPCP ((Rp)-3b) were prepared through
a stepwise coupling procedure following the synthetic route
shown in Scheme 1a. Starting from unsubstituted [2.2]para-
cyclophane, an aromatic substitution with bromine under iron
catalysis resulted in (rac)-4-bromo[2.2]paracyclophane (1) in
excellent yield,53 followed by a preparative HPLC with a chiral
stationary phase54 to separate the two enantiomers of racemic 1,
(Sp)-1a and (Rp)-1b. Subsequently a Pd-catalysed Suzuki cross-
coupling of (Sp)-1a and (Rp)-1b with 4-pyridyl boronic acid was
carried out to obtain (Sp)-2a and (Rp)-2b with 93% ee and 99% ee
respectively and 79% yield. Aerwards, (Sp)-2a and (Rp)-2b was
treated with methyl iodide in the nal quaternization step in
order to obtain the MPCP dye enantiomers (SP)-MPCP ((Sp)-3a)
and (RP)-MPCP ((Rp)-3b) in 55% yield (see Section 4 in ESI† for
the synthetic details).
The new, chiral paracyclophane dye, (SP)-MVCP ((Sp)-6a) was
designed in order to obtain a dye with longer excitation wave-
length, following the synthetic route shown in Scheme 1b. 4-
Formyl[2.2]paracyclophane 4 was initially obtained from
unsubstituted [2.2]paracyclophane through a Rieche for-
mylation in quantitative yield.55 The enantiomers of the alde-
hyde 4 were then prepared following the literature procedure,56
i.e. 4 was condensed with (R)-7 by reuxing in toluene to obtain
the diastereomeric imines 5, which were then separated by
fractional crystallization in n-hexane to obtain the analyticallyScheme 1 Synthesis route of (a) MPCP dye enantiomers, (SP)-MPCP and
9422 | Chem. Sci., 2021, 12, 9420–9431pure (Sp,R)-5a in 27% yield. Acid-labile compound 5a was
hydrolysed by ltration over a column of silica using dichloro-
methane as the eluent to obtain the enantiopure aldehyde (Sp)-
4a with 98% ee.56 (Sp)-4a was then treated with 1,4-dime-
thylpyridinium iodide in a Knoevenagel condensation with
piperidine in methanol to yield chiral paracyclophane (SP)-
MVCP dye ((Sp)-6a) in 22% yield (see Section 5 in ESI† for the
synthetic details).
General protocol for ECD and FDCD measurements
In contrast to ECD, measurement protocols for FDCD
measurements were lacking in the literature, which was
particularly hindering because FDCD is more complex and can
be artefact-prone than ECDmeasurements (see below). We thus
rst optimized the measurement parameters for FDCD (proce-
dures, parameters, conditions), providing a transferable and
general FDCD measurement protocol which will be of utility
even beyond supramolecular systems (see further below and
Section 7 in ESI†).
It is well known that ECD measurements should be per-
formed on samples with an absorbance value between 0.4 to 1
(theoretically a value of 0.87 is optimal for ECD measure-
ments).35,36 Technically, ECD measurements are conducted at
a xed direct current (DC) voltage by automatically varying the
high tension (HT) voltage on the photomultiplier (PM) tube of
the ECD detector. The obtained ECD signal is proportional to
the concentration of the chiral chromophore.
FDCD measurements can be performed on a CD spectrom-
eter that is equipped with an FDCD accessory, for instance
where a long-pass lter (LP-lter) and lenses are installed in
a 90-degree geometry to the excitation light source, directing the
uorescence light towards an additional light detector, e.g. a PM
tube,57 see also Fig. 1. Contrary to ECD, FDCD measurements
are conducted at a varying DC voltage by xing the HT voltage
on the PM tube of the FDCD detector. There are two different
uorescent-based chiroptical parameters that can be obtained
from uorescence-detected circular dichroism spectroscopy. (i)(RP)-MPCP and (b) enantiopure (SP)-MVCP dye.
© 2021 The Author(s). Published by the Royal Society of Chemistry
Fig. 3 (a) Schematic representation of a 1 : 1 host–dye complex
formation between the chiral chromophoric MPCP dye and the non-
chromophoric host CB8. (b) ECD and (c) DF spectra of the MPCP dye
enantiomers (Rp)-MPCP (45 mM) and (Sp)-MPCP (45 mM) in the absence
(dashed lines) and presence of CB8 (solid lines) (45 mM) in water.
Parameters used: HT ¼ 650 V, BW ¼ 4 nm, Acc ¼ 20, LP-filter ¼
420 nm. (d) ECD and (e) DF spectra of MPCP dye enantiomers (Rp)-
MPCP (100 nM) and (Sp)-MPCP (100 nM) in the absence and presence
of CB8 (100 nM) in water. Parameters used: HT ¼ 800 V, BW ¼ 4 nm,
Acc ¼ 20, LP-filter ¼ 420 nm. The measurement parameters, HT
voltage (HT), bandwidth (BW), number of accumulations (Acc) as well
as the long-pass filter (LP-filter) were kept constant for each set of
experiments.























































































View Article OnlineThe “differential circularly polarized uorescence excitation”
(oen termed as DF) can be dened as the uorescence inten-
sity difference resulting from excitation with le (FL) and right
(FR) circularly polarized light, see eqn (1). The DF value is
concentration dependent and can be considered as the
analogue to the ECD value (also known as the ellipticity, q), even
though both quantities have different units. (ii) In order to
arrive at a concentration-independent quantity, the DF value
can be normalized by the total uorescence of the sample (FL +
FR), which is measured as the DC component, see eqn (2). This
parameter is typically referred to as the FDCD value. Albeit the
derivation is mathematically more complex, the FDCD value
can be considered as the uorescence-based chiroptical
analogue of the concentration-independent molar circular
dichroism (D3), see also Section 7.3 in the ESI.†
DF ¼ FL  FR (1)
FDCD ¼ DF
DC
¼ FL  FR
FL þ FR (2)
Practically, we recommend that the FDCD measurement set-
up is made as such that both the DF signal and the DC voltage
(¼ total uorescence) are collected in two separate channels,
and that these measurements are performed for both the
sample and solvent (“blank”). The FDCD spectra are then ob-
tained by rst subtracting the solvent spectra from the sample
spectra, arriving at baseline-corrected DF and DC spectra. From
this, normalized FDCD spectra are obtained by dividing the
baseline-corrected DF spectra by the corrected DC voltage.
Unlike ECD measurements, recording DF offers additional
variability in choosing measurement parameters. For instance,
the HT voltage can be tuned independently from the bandwidth
(BW), through which the signal intensity can be adjusted and
thereby a wider measurement range than available for ECD
measurements can be reached – examples are shown in the next
section.38 Few studies have focused on using the DF component
of the FDCD data directly for sensing.58,59 Therefore, we rst
optimized the measurement parameters for the DF signal with
respect to bandwidth and HT voltage. Recommended
measurement options and empirical correlation curves between
signal intensity, HT voltage and bandwidth are discussed in the
ESI† (see Section 7). In general, we suggest that both DF and
FDCD spectra are considered for data analysis and evaluation.
Comparison of sensitivity for FDCD and ECD measurements
In order to compare the sensitivity of FDCD and ECD
measurements, we rst investigated a simple 1 : 1 host–dye
complex of a chiral chromophoric dye with a non-chromophoric
host (see Fig. 3a). As chiral chromophoric indicator dyes, the
MPCP dye enantiomers, (SP)- and (RP)-MPCP were utilized with
CB8 as the non-chromophoric host (see Fig. 2a and b). Both (SP)-
and (RP)-MPCP were found to display strong ECD bands on
account of their rigid, planar-chiral structure. Recently, we have
shown that racemic MPCP forms an inclusion complex with
CB8, which is extremely stable, Ka ¼ 3.89 (0.99)  1012 M1 in
water.53 Thus, in the absence of competing guests the© 2021 The Author(s). Published by the Royal Society of ChemistryCB8$MPCP complex remains fully intact even upon dilution to
the nanomolar concentration regime, which was veried by
uorescence titration experiments. This supramolecular
system, extended now to the use of chiral dyes, therefore
provided an ideal starting point to evaluate if the uorescence-
based DF quantity can be also under practical conditions more
sensitive than ECD. At micromolar concentrations, both the DF
and ECD spectra of the complexes of (SP)- or (RP)-MPCP and CB8
show clearly dened signals with maxima at 275 nm and
340 nm for the bound, and at 264 nm and 333 nm for the
unbound guest, see Fig. 3b, c and S22.† Note the stronger signal
differences in the DF than in ECD between CB8-bound and free
MPCP; host–guest binding commonly leads to more
pronounced changes in the emission than the absorbance
spectra, and thus one can generally expect to nd larger signal
differences inDF than in ECD. This feature can be advantageous
for sensing applications that rely on signal differences, e.g. DF-
based quantication of the drug memantine through the
CB8$MPCP reporter pair in blood serum, see further below. ForChem. Sci., 2021, 12, 9420–9431 | 9423























































































View Article Onlinecomparing spectra obtained at different concentrations and
measurement settings, the conversion of the DF spectra into
concentration-independent FDCD spectra is useful; see Fig. S22
in the ESI.† These FDCD spectra can be related to the measured
ECD spectra through converting each of them into molar
circular dichroism (D3) values, see Section 7.3 in the ESI.†
Indeed, FDCD and ECD data conversion for the CB8$MPCP
reporter pair yielded very similar D3-spectra (Fig. S23†), as is
theoretically expected.38,48,49
The new obtained (SP)-MVCP dye (see Fig. 2b) was also
investigated to study its binding properties with CB8. (SP)-MVCP
shows absorption bands in the 350 nm to 450 nm region, which
is by 46 nm red-shied absorption compared to the MPCP dye.
Similar to MPCP, (SP)-MVCP shows a strong uorescence
enhancement on binding to CB8 (Fig. S24c†). At micromolar
concentrations of (SP)-MVCP and CB8, both the DF and ECD
spectra show a clearly dened signal with signal maxima at
299 nm and 386 nm for the bound, and at 285 nm and 363 nm
for the unbound guest (Fig. S24†). Binding to CB8 also resulted
in an enhancement in the DF signal accompanied by a bath-
ochromic shi in both ECD and DF signals. The red-shied
absorption of CB8$(SP)-MVCP complex compared to
CB8$MPCP can be advantageous for sensing studies in real
biological media, see below.
The comparison of the resulting DF and ECD spectra for the
CB8$MPCP system at submicromolar concentration are
striking: while it is not possible to detect clear ECD signals at
low concentrations (<1 mM), DF signals remain readily
measurable even at 100 nM (Fig. 3d, e and S25†), pointing to at
least an order of magnitude higher sensitivity of FDCD over
ECD measurements. DF and FDCD spectra of the CB8$MPCP
complex showed a more “noisy” character than ECD spectra,
which also holds true for the other systems that we have
investigated and that were reported in the literature.38,58 This
obstacle can be overcome by either increasing the number of
accumulations (Acc) in the measurement (Fig. S25c and d†) or
by utilizing DF in the single-wavelength measurement mode, as
is pointed out on several occasions in the main text and ESI.†
For e.g., investigations of the CB8$(Rp)-MPCP and CB8$(Sp)-
MPCP complexes upon dilution to 50 nM provided single-
wavelength DF values that were reproducible and consistent.
As an additional test, the calculated FDCD value was constant
across a wide concentration range, ruling out photophysical or
other artefacts. Conversely, no meaningful ECD signal could be
reproducibly obtained in the nanomolar concentration range
(see Tables S2 and S3 in ESI†).
The sensitivity of FDCD vs. ECD measurements was also
assessed for self-assembled chemosensors composed of CB8
and the dicationic racemic dye MDPP (see Fig. 2a and b), which
are known to subsequently bind chiral aromatic guests, e.g. Phe,
Trp and many other aryl-moiety containing species.14 Our
previous investigations have shown that these 1 : 1 : 1 hetero-
ternary complexes (see Fig. 4a) show characteristic induced
ECD signals, which can be used for analyte differentiation and
reaction monitoring at micromolar concentrations (20 to 500
mM).14 Full spectral measurements and single-wavelength DF
recordings were then utilized to compare the sensitivity of DF9424 | Chem. Sci., 2021, 12, 9420–9431over ECD measurements (Fig. S27, Tables S4, S5, S8 and S9 in
ESI†). Again, a remarkably higher sensitivity of DF over ECD was
evidenced by the results, where only DF measurements gave
reliable values at the low micromolar concentration regime; see
for instance Table S4† that depicts the data for CB8$MDPP
receptor complex with the peptidic guest L-Phe-L-Ala. Excess of
the chiral guest over the host was used in these examples to
ensure a sufficient degree of complexation of the chromophoric
and emissive host.
Because achiral chromophoric/emissive hosts do not
contribute to the chiroptical signals, they can be used in excess
in both ECD and FDCDmeasurements to enhance the degree of
analyte complexation, see for instance the ECD- and DF-moni-
tored titration of CB8$MDPP receptor to L-Phe–Gly in Fig. S28.†
A rise of the ECD and DF values by increasing the receptor
concentration was observed until the degree of complexation
reached unity, beyond which the ECD and DF signals saturated.
Conversely, in conventional absorbance- or emission-based
assays, such an approach is generally infeasible as it causes
an undesirable signal increase proportional to the concentra-
tion of unbound host. For instance, the uorescence intensity
displayed a rather linear increase for the aforementioned
system (Fig. S28c†).Detection of chiral chromophoric analytes as well as label-free
endpoint and continuous reaction monitoring
Combining FDCD and ECD measurements is potentially more
informative, thereby providing additional, useful chiroptical
information about the analyte present than the individual
methods on their own. We evaluated this for the system
composed of the achiral chromophoric CB8$MDPP chemo-
sensor interacting with chiral Phe- and Trp-containing species
resulting in 1 : 1 : 1 hetero-ternary complexes in aqueous media
(see Fig. 4a).14 Unlike the results obtained in ECD measure-
ments where all combinations gave rise to chiroptical signals,
FDCD is far more selective, where only the combination of
CB8$MDPP with Phe but not with Trp species gave rise to
induced chiroptical FDCD effects (Fig. 4b, c and S26†). This can
be understood because Trp quenches the emission of
CB8$MDPP while Phe binding leads to a slight bathochromic
shi and emission increase (Fig. S26c†). Furthermore, it was
found that N-terminal Phe containing dipeptides can be
distinguished from C-terminal Phe variants both by FDCD and
ECD, see Fig. 4b, c and S27.† (However, different Phe–X
dipeptides remained indistinguishable by both techniques
utilizing CB8$MDPP as the host.) Combined information of
FDCD and ECDmeasurements were for instance useful to verify
that the CB8$MDPP receptor targets phenylalanine and not the
multiple tyrosine residues present in the protein insulin (see
the amino acid sequence shown in Fig. 2c), because binding to
tyrosine would have resulted in no FDCD signals due to emis-
sion quenching,60 see further below. This nding agrees with
the binding geometry deduced from the crystal structure of the
host CB7 with insulin.61
Practically important, the combined use of FDCD and ECD
will be advantageous for a sensitive and selective endpoint and© 2021 The Author(s). Published by the Royal Society of Chemistry
Fig. 4 (a) Schematic representation of a 1 : 1 : 1 ternary complex formation between the achiral chromophoric CB8$MDPP receptor and the
chiral analyte. (b) ECD and (c) FDCD spectra of CB8$MDPP receptor (20 mM) in the absence (dashed lines) and presence (solid lines) of several
amino acids, amino acid derivatives and dipeptides (50 mM) in water. Parameters used: HT ¼ 520 V and 510 V (for dipeptides), BW¼ 4 nm, Acc ¼
20, LP-filter ¼ 515 nm. (d) Time course DF measurement of CB8$MDPP (20 mM) in the presence of (1R,2R)-PPO (100 mM) in different solvent
systems: 50 mM acetate buffer at pH 4.75 (black), water at pH 7 (red) and 50 mM carbonate buffer at pH 10 (blue) when monitored at 350 nm.
Parameters used: HT ¼ 520 V, BW ¼ 4 nm, Acc ¼ 20, LP-filter ¼ 515 nm, data pitch ¼ 5 s, D. I. T ¼ 8 s, tmeasure ¼ 14 h. The DF signals were
corrected for the photoselection artefacts arising from the CB8$MDPP receptor, see Section 9.1.1 in ESI.†























































































View Article Onlinelabel-free continuous reaction monitoring of (bio)chemical and
(bio)physical processes in real time. Several examples for both
purposes, utilizing supramolecular receptors e.g. cucurbit[n]
urils,62–64 calix[n]arenes,64,65 molecular tubes,11,66 and CB8$dye
chemosensors14,60 reported so far are based on absorbance,
emission and ECD spectroscopy. We demonstrate here repre-
sentative examples for the use of FDCD in combination with
supramolecular hosts for (i) endpoint and (ii) continuous
reaction monitoring:
(i) The racemisation of amino acids remains an important
obstacle under synthetic conditions in organic solvents. In our
previous study we have adopted ECD measurements in the
presence of CB8$MDPP for monitoring the base-catalysed rac-
emisation of both L-Phe and L-Phe–Gly in water, DMF and
ethylene glycol at elevated temperatures.15 Herein, the DF signal
was utilized for the endpoint monitoring of racemisation of
amino acids using the CB8$MDPP reporter pair. In practice,
aliquots of the reaction mixture were added into an aqueous
solution of the CB8$MDPP chemosensor, and the DF and ECD
signal at 338 nm (for L-Phe) and 333 nm (for L-Phe–Gly), was
measured before and aer the chemical reaction (Fig. S29 and
S30†). Pleasingly, the inuence of the reaction conditions on
the racemisation of amino acids monitored via DF measure-
ments are in full agreement with the more cumbersome HPLC-
based literature procedure.67 The chemosensor-based approach
veries that water suppresses the racemisation of L-Phe and L-
Phe–Gly while DMF leads to the fast loss of the chirality. Under
the conditions tested, both DF and ECD were equally suitable.
However, DF has the additional advantage of its higher sensi-
tivity, e.g. for detections at lower concentration ranges.
(ii) If the supramolecular chemosensors are compatible with
the reaction conditions (solvent, pH, additives, temperature
etc.) they can also be directly added to the reaction mixture and
a continuous signal read out can be recorded. For instance,
adding 20 mM of CB8$MDPP receptor to 100 mM (1R,2R)-1-
phenylpropylene oxide ((1R,2R)-PPO) in deionized water (pH 7),
50 mM acetate buffer (pH 4.5) and 50 mM carbonate buffer (pH© 2021 The Author(s). Published by the Royal Society of Chemistry10) allowed for in situ monitoring of the hydrolysis of the
epoxide. Both time course DF and ECD spectral measurements
revealed that complete hydrolysis and racemisation occurred in
acidic environment aer 4 h and under neutral conditions aer
12 h, while the epoxide did not hydrolyse under basic condi-
tions, see Fig. 4d, S31 and S32.† This observation is in agree-
ment with expectations for secondary-carbon containing
epoxides that likely follow a proton catalysed SN1 type hydrolysis
mechanism (see Scheme S1 in ESI†).68,69
Similarly, the hydrolysis of phenyl-b-D-galactopyranoside by
b-galactosidase, which is a commonly studied reaction in cell
biology,70,71 can be monitored with the help of CB8$MDPP
receptor by DF and ECD recordings. The time course DF and
ECDmeasurements shows a gradual decrease in the intensity of
both induced DF and ECD signals upon addition of b-galacto-
sidase, enabling real time monitoring of the enzymatic
conversion (Fig. S33 and S34†).Uncovering of hidden aggregation phenomena by FDCD
The achiral emissive endo-functionalizedmolecular tubeMT (see
Fig. 2a) is known to bind selectively polar guests with hydrogen-
bond accepting capacities such as dioxane, esters and epoxides in
aqueousmedia with Ka up to 10
5M1.11,72,73 For instance, both the
chiral guest (1R,2R)-1-phenylpropylene oxide ((1R,2R)-PPO) and
its enantiomer (1S,2S)-1-phenylpropylene oxide ((1S,2S)-PPO) are
complexed with Ka ¼ 8.97 (0.9)  104 M1 by MT in water.11
This interaction gives rise to a strong ECD signal,11 e.g. approx.
89 mdeg at 254 nm at 100 mM host and 500 mM of the guest.11
Applying FDCD measurements to this system, we were surprised
that the induced FDCD signals were markedly weaker, approx.
10 mdeg at 254 nm at the same concentrations, see Fig. 5a,
b and S35.† Besides, the FDCD spectra of the control experiment
with achiral MT receptor showed pronounced signals in the
excitation peak region for the achiral host alone (see Fig. S35d†),
which – of course – do not reect chiroptical properties but must
arise from anisotropic excitation, also known as photoselection,Chem. Sci., 2021, 12, 9420–9431 | 9425
Fig. 5 Concentration dependent (a) ECD and (b) FDCD spectra of freshly prepared MT receptor in presence of (1R,2R)-PPO in water. The inset
show the zoomed in ECD signals in the 240 nm to 320 nm region. Parameters used: BW¼ 4 nm, Acc¼ 20, LP-filter¼ 380 nm. (c) FDCD signal at
300 nm of theMT receptor (100 mM) in water on increasing the temperature from 5 C to 60 C (red line) and on cooling the solution back from
60 C to 5 C (green line). (d) DLS measurements showing intensity distribution versus particle diameter of MT receptor solution (100 mM) in
water. Parameters used: material RI ¼ 1.45, dispersant RI ¼ 1.330, viscosity ¼ 0.8872 cP, measurement position ¼ 4.65 mm, attenuator ¼ 11. (e)
Schematic representation showing the complex formation between the achiral chromophoric MT host and the chiral epoxides in their non-
aggregated state at low concentrations and upon aggregation at higher concentrations and lower temperature.























































































View Article Onlineand from instrument-related artefacts.38,74,75 In essence, the larger
the emissive compound, e.g. the macrocyclic host, and the higher
the viscosity of the medium, the larger photoselection artefacts
will be observed due to restricted rotation of the emitter38,76 (see
Section 9.1 in ESI† for a detailed explanation on photoselection
artefacts in FDCD and suggested artefact-subtraction proce-
dures). Striking changes to the FDCD and ECD spectra were
observed upon dilution. A strong reduction in the ECD signals
corresponding to the decrease in host–guest concentration was
observed, while the FDCD signal even inverted its sign upon
dilution, see Fig. 5a, b, S36 and S37.† The inuence of photo-
selection artefacts or anisotropy of the system in the measured
ECD and FDCD spectra at higher concentrations were evaluated
by measuring the linear polarization components, i.e. linear
dichroism (LD)77,78 and linear birefringence (LB)78,79 in case of
ECD, and uorescence-detected linear dichroism (FDLD)38,80 in
case of FDCD (Fig. S39 and S40†). The measured LD and LB
values are only modest in magnitude, indicating that the
observed ECD signal are direct measure of the chiroptical
behaviour of the system. In contrast, FDLD spectra showed
strong signals in the region where the FDCD bands are found for
the achiralMT receptor (Fig. S40†), indicating a strong inuence
of uorescence anisotropy. Clearly, the FDCD signal should be
considered for this system as an apparent one which does not
directly report on chiroptical properties but also contains other
contributions that are indicative of uorophore orientation.
Thus, measurements for the MT$(1R,2R)-PPO complex were also9426 | Chem. Sci., 2021, 12, 9420–9431carried out on an artefact-free FDCD spectrometer utilizing an
ellipsoidal mirror,81 at receptor concentration of 100 mM. In this
case, the FDCD spectrum obtained at a high micromolar
concentration (100 mM) resembles the FDCD spectrum collected
at lower concentrations on the standard FDCD spectrometer
(Fig. S36 and S43†). We concluded that something unusual
occurs at higher concentration of MT and guests that was
undetected previously by ECD, uorescence, absorbance and
NMR measurements.11 We propose that MT and the MT$PPO
complexes form supramolecular aggregates at higher micro-
molar concentrations (see Fig. 5e) that lead to an enhanced ECD
signal and sizeable uorescence-detected linear dichroism
contributions to the FDCD band. MT is hydrophobic, such that
aggregation formation in water is plausible. Additional experi-
ments support the aggregation hypothesis: Dynamic Light Scat-
tering (DLS) data (Fig. 5d and S48†) and FDCD measurements at
longer time intervals (Fig. S44†) revealed an “aging phenom-
enon” of theMT receptor stock solution. Moreover, the observed
FDCD signals for the MT receptor were temperature-dependent
(Fig. 5c and S45†) and that the uorescence intensity–concen-
tration plot shows a concave curvature (Fig. S46†). Concentration-
dependent DOSY NMR spectra in D2O displayed a slower diffu-
sion rate of MT at higher concentrations (Fig. S47†), which also
support the aggregation hypothesis. Clearly, FDCD-based inves-
tigations can uncover interesting supramolecular phenomena
that were invisible to ECD and other spectroscopic techniques
alone.© 2021 The Author(s). Published by the Royal Society of Chemistry
Fig. 6 (a) Schematic representation depicting the formation of a 1 : 1
CB8$MPCP complex, followed by the displacement of MPCP from the
host cavity upon addition of a higher binding analyte like memantine.
DF spectra of (b) CB8$(RP)-MPCP (20 mM) and (c) CB8$(SP)-MPCP (20
mM) in human blood serum before and after addition of memantine (20
mM). Parameters used: HT ¼ 800 V, BW ¼ 4 nm, Acc ¼ 20, LP-filter ¼
515 nm. The insets show the variation in DF signal at 340 nm on
stepwise addition of memantine.























































































View Article OnlineBackground reduction in complex systems and chromophoric
biouids
It is now shown that the host–guest binding coupled FDCD
technique can provide background-reduced signals compared
to ECD and standard absorbance or uorescence measure-
ments. This is of relevance if a chiral analyte should be detected
in the presence of chiral (and chromophoric) substances (e.g.
proteins, DNA) or complex media such as biouids that show
strong absorbance, emission and ECD signals. As model cases,
two supramolecular systems were investigated:
(i) The binding of the protein insulin by the chemosensor
CB8$MDPP can be followed by ECD,16 but one nds some
contribution from the ECD signal of the protein at <310 nm, see
Fig. S49 in ESI.† Conversely, for FDCD, a protein-based chi-
roptical signal contribution was completely absent when
utilizing a 515 nm long-pass lter and only the induced FDCD
signal from CB8$MDPP complex bound to and located in the
chiral protein-environment is observed (Fig. S49†).
(ii) To showcase the power of FDCD-based detection
schemes, human blood serum (HS) was utilized as strongly
chromophoric and autoemissive biouid that contains many
chiral components. We have recently introduced the rst
emission-based supramolecular assay for the detection of Alz-
heimer's drug memantine in human blood serum using the
aforementioned CB8$MPCP reporter pair.53 In the uorescence-
based assay mode, alterations of the total uorescence back-
ground due to sample-to-sample differences can complicate the
situation. With the FDCD technique, that is selectively reporting
only on chiral and emissive species, the background was
expectedly much lower than for conventional emission or ECD
spectroscopy. In fact, only by DF and not by ECD, was it possible
to quantitatively detect the achiral drug memantine in human
blood serum in the low micromolar concentration regime
(Fig. 6a, c and S50–S53†). For instance, the addition of 15 mM of
memantine to a solution of CB8$(RP)-MPCP or CB8$(SP)-MPCP
(reporter pair at 20 mM) in human blood serum led to a DF
signal change by +16 V or 15 V respectively, upon displace-
ment of the chiral emissive dye from the CB8 cavity, while the
ECD signals did not show any signicant alteration (Fig. 6b, c
and S50–S53†). Curiously, in the case of using the enantiomeric
indicator dyes (SP)-MPCP and (RP)-MPCP the behaviour was
similar but not identical, see the ECD and DF spectra and
titration curves in Fig. 6b, c and S50–S53 in ESI.† These differ-
ences may be originating from the diastereomeric interaction of
the chiral indicator dye MPCP with the chiral components in
blood serum, e.g. human serum albumin and other chiral
proteins with large binding pockets. For developing practical
assays in biouids containing chiral compounds, it is therefore
advisable to access both chiral forms of a dye or host, as the
combined chiroptical information obtained by both enantio-
mers can enrich the understanding of the system and help to
identify artefacts.
Both CB8$(RP)-MPCP and CB8$(SP)-MPCP are from a photo-
physical point of view not ideally suited for sensing in HS
because the ECD and DF signals of the complex lie in the same
region as the background DF and ECD signals arising from HS© 2021 The Author(s). Published by the Royal Society of Chemistryalone. The CB8$(SP)-MVCP reporter pair, which shows a more
red-shied absorption compared to the CB8$MPCP system,
therefore appears to be an interesting candidate for sensing
studies in human blood serum. The addition of 16 mM of
memantine to a solution of CB8$(SP)-MVCP (reporter pair at 20
mM) in human blood serum led to a DF signal change by4 V at
407 nm monitoring wavelength, see Fig. S54 and S55 in ESI.†
Interestingly, when using CB8$(SP)-MVCP instead of CB8$(SP)-
MPCP as a reporter pair, also ECD-based detection of mem-
antine in blood serum is feasible, see Fig. S54 and S55 in ESI.†Discussion
The commonly applied chiral-analytical tools in drug discovery,
molecular congurational and conformational analysis include
ECD, chiral HPLC, NMR, Raman optical activity (ROA) and
optical rotatory dispersion (ORD). However, despite being
widely used, these methods come with their own drawbacks.
For example, NMR and chiral HPLC analysis require access to
high-cost equipment and are not suitable for high-throughput
measurements. Another important limitation is the low sensi-
tivity, e.g. of ORD, thereby requiring high sample concentration
for the measurements. This has impeded the investigation of
biological analytes at their clinically relevant concentration
levels in solution, as well as of large biomolecules andChem. Sci., 2021, 12, 9420–9431 | 9427























































































View Article Onlineaggregation-prone systems that needs to be measured at low
concentrations. Furthermore, real biological media that contain
a range of chromophoric chiral substances give rise to strong
signal backgrounds in the ECD, ROA and ORD spectra, making
the analysis practically difficult. Most of these limitations can
be overcome by the use of emission based spectroscopic tech-
niques such as FDCD and CPL, which combine the advantages
of both chiroptical and uorescence techniques. FDCD (and
CPL) possess additional merit for sensing applications in
(complex) biouids as only the compounds that are both chiral
and uorescent give rise to an emission-based chiroptical
signal.82–84 We believe that FDCD has an edge over CPL for the
differentiation of analytes by spectroscopic ngerprints: rstly,
excitation spectra are typically structured and reect several S0
/ Sn (n $ 1) transitions while emission spectra arise usually
only from the S1/ S0 (or T1/ S0) transition(s) and are typically
featureless.57,85 Secondly, FDCD measurements can be readily
obtained (even simultaneously to ECD) by upgrading commer-
cial ECD spectrometers with a FDCD set-up,57,58,86 while CPL
measurements are oen difficult to carry out as they require
purchase of a high-cost stand-alone CPL equipment or
specialized expertise to construct home-build CPL acces-
sories.58,87–89 Despite these potential advantages, FDCD
measurements had only rarely been performed, mostly on
chiral chromophores,90,91 protein–ligand51,92,93 and nucleobase
systems.94,95
The sensitivity of a supramolecular assay is obviously also
limited by the degree of complexation, which is a function of the
binding affinity and concentration of the host and analyte. In
spectroscopic assays, the common strategy to enhance the degree
of complexation is the increase of the concentration of the
spectroscopically silent component, which is mostly the analyte.
However, in some cases this strategy is awed, e.g. if the spec-
troscopically silent component is expensive, shows solubility
limitations,96 shows undesirable aggregation tendencies (see
above) or is present in very low concentration in the analytical
sample.15,53 In contrast, FDCD analysis can conveniently be
carried out in the presence of excess of uorescent host, allowing
for an increase of the degree of complexation of the chiral target
analyte. Thus, FDCD-based sensing can be a convenient choice to
study the interaction of chromophoric receptors with biomole-
cules or proteins whose concentration can be kept low. For
comparison, in standard uorescence-based assay, it is generally
infeasible to use a high excess of the uorescent compound. The
design of new novel chiral indicator dyes as well as protein- and
analyte-binding emissive hosts with improved photophysical
properties will increase the scope of FDCD-based (and ECD-
based) supramolecular applications in biorelevant media.
Conclusion
Herein, we provide for the rst time an exploration of FDCD
measurements on (synthetic) supramolecular complexes in
aqueous media. At least an order of magnitude higher sensi-
tivity can be exploited with FDCD compared to ECD measure-
ments, and even the nanomolar sensitivity can be reached by
FDCD in favourable circumstances, which is beyond the scope9428 | Chem. Sci., 2021, 12, 9420–9431of most other techniques used for characterization of supra-
molecular systems. The high sensitivity of FDCD will be
advantageous for sensing in real biological media where the
analytes are mostly present in the lowmicromolar to nanomolar
concentration regime.
In addition to a sensitivity enhancement, the combined use
of FDCD and ECD measurements can uncover supramolecular
processes, e.g. aggregation phenomena and provide comple-
mentary information that is useful for distinguishing chiral
analytes from each other, and through which the target binding
sites of the host can be identied, e.g. Phe- from Trp residues in
proteins. FDCD spectra can be informative, but it is important
to consider anisotropic excitation/photoselection and
instrument-related artefacts that can cause apparent FDCD
signals, unless a dedicated artefact-free FDCD setup is utilized.
This work also established FDCD measurements for label-free
reaction monitoring, both in an endpoint assay version and
for continuous reaction monitoring even in the presence of
other chromophoric compounds, as found in biouids such as
human blood serum, which can be employed for faster and
more facile analysis of chemical or enzymatic transformations
compared to other established methods such as HPLC-MS.
In summary, FDCD was shown to be a highly sensitive and
information-rich spectroscopic method for the selective chi-
roptical analysis of uorescent supramolecular host–guest
systems both in aqueous solutions and biorelevant media. This
work not only established the use of FDCD (and ECD) for
a range of host–guest and host–protein complexes, but also
provides a comprehensive user guide and recommendation for
the most effective and general use of FDCD spectroscopy. We
believe that the combined use of FDCD and ECD has a wide
applicability and can be readily applied to other supramolecular
chiral systems.
AbbreviationsECD© 2021Electronic circular dichroism
FDCD Fluorescence-detected circular dichroism
CPL Circularly polarized luminescence
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Data for this paper, including synthesis of the chiral para-





MABGN-NUHFF-ZZZ. In addition, the datasets for all the
spectra in the manuscript are provided as additional supple-
mentary material.
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